Evidence map›Paper›PMID 29263921›Full record

ArticleSignal transduction and targeted therapy

Angiotensin type 2 receptor activation promotes browning of white adipose tissue and brown adipogenesis.

Aung Than, Shaohai Xu, Ru Li, Melvin Khee-Shing Leow, Lei Sun, Peng Chen

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Signal transduction and targeted therapy. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Adipocyte Browning: A Promising Avenue in Anti-Obesity Therapy.International journal of molecular sciences · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Weighing in on the role of brown adipose tissue for treatment of obesity.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2024
    Review
  8. Article
  9. Adipocyte · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. The Angiotensin ATPharmacological reviews · 2022
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Asthma and obesity: endotoxin another insult to add to injury?Clinical science (London, England : 1979) · 2021
    Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Aung ThanSchool of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore, Singapore.
Shaohai XuSchool of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore, Singapore.
Ru LiSchool of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore, Singapore.
Melvin Khee-Shing LeowEndocrine and Diabetes, Tan Tock Seng Hospital, Singapore, Singapore.
Lei SunDuke-NUS Graduate Medical School, Singapore, Singapore.
Peng ChenSchool of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore, Singapore.
Nanyang Technological University · SGDuke-NUS Medical School · SGTan Tock Seng Hospital · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brown adipose tissue dissipates energy in the form of heat. Recent studies have shown that adult humans possess both classical brown and beige adipocytes (brown-like adipocytes in white adipose tissue, WAT), and stimulating brown and beige adipocyte formation can be a new avenue to treat obesity. Angiotensin II (AngII) is a peptide hormone that plays important roles in energy metabolism via its angiotensin type 1 or type 2 receptors (AT1R and AT2R). Adipose tissue is a major source of AngII and expresses both types of its receptors, implying the autocrine and paracrine role of AngII in regulating adipose functions and self-remodeling. Here, based on the

Identifiers

PMID29263921
PMCPMC5661636
OpenAlexW2654687499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.